🇺🇸 FDA
Patent

US 9758556

Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

granted A61KA61K31/495A61K38/00

Quick answer

US patent 9758556 (Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5) held by The Regents of the University of California expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/495, A61K38/00, A61K38/1709, A61P